COVID-19 trials registries data warehouse

 Return to trial list

Trial - NCT04980534


Column Value
Trial registration number NCT04980534
Full text link
Last imported at : July 29, 2021, noon
Source : ClinicalTrials.gov

First author
Last imported at : July 29, 2021, noon
Source : ClinicalTrials.gov

Not reported

Contact
Last imported at : July 29, 2021, noon
Source : ClinicalTrials.gov

Not reported

Registration date
Last imported at : July 29, 2021, noon
Source : ClinicalTrials.gov

2021-07-28

Recruitment status
Last imported at : Oct. 22, 2021, 10 a.m.
Source : ClinicalTrials.gov

Completed

Study design
Last imported at : July 29, 2021, noon
Source : ClinicalTrials.gov

RCT

Allocation
Last imported at : July 29, 2021, noon
Source : ClinicalTrials.gov

Randomized

Design
Last imported at : July 29, 2021, noon
Source : ClinicalTrials.gov

Parallel

Masking
Last imported at : July 29, 2021, noon
Source : ClinicalTrials.gov

Open label

Center
Last imported at : March 15, 2023, 4 a.m.
Source : ClinicalTrials.gov

multi-center

Study aim
Last imported at : July 29, 2021, noon
Source : ClinicalTrials.gov

Treatment

Inclusion criteria
Last imported at : April 14, 2022, 11:30 p.m.
Source : ClinicalTrials.gov

the eligibility criteria for inclusion in the study were as follows: male and female hospitalized patients who have signed an informed consent. aged between 18-85 years old. rt-pcr confirmed covid-19. fever (over 37.2 celsius degrees). ct scan percentage area of lung involvement with ground-glass opacities < 50 %. respiratory rate < 20-30 /min spo2 ≥ 95%. the exclusion criteria were as follows: oxygen support (ventilation and non-invasive) uncompensated or exacerbated concomitant diseases or conditions that may complicate or make the patient's participation in the study impossible, or make it difficult to explain clinical findings. any known intolerability to any of the study regimens' components. patient's family or official relations with a member of staff of the clinical site. patient's failure to assess his/her physical and/or emotional condition. patient's failure to comply with the study requirements. patient's refusal to participate in the study. pregnancy or breastfeeding.

Exclusion criteria
Last imported at : April 14, 2022, 11:30 p.m.
Source : ClinicalTrials.gov

None

Number of arms
Last imported at : July 29, 2021, noon
Source : ClinicalTrials.gov

3

Funding
Last imported at : July 29, 2021, noon
Source : ClinicalTrials.gov

Catalysis SL

Inclusion age min
Last imported at : July 29, 2021, noon
Source : ClinicalTrials.gov

18

Inclusion age max
Last imported at : April 14, 2022, 11:30 p.m.
Source : ClinicalTrials.gov

85

Countries
Last imported at : July 29, 2021, noon
Source : ClinicalTrials.gov

Kazakhstan

Type of patients
Last imported at : July 29, 2021, noon
Source : ClinicalTrials.gov

Mild/moderate disease at enrollment

Severity scale
Last imported at : July 29, 2021, noon
Source : ClinicalTrials.gov

2: Mild/moderate disease at enrollment

Total sample size
Last imported at : July 29, 2021, noon
Source : ClinicalTrials.gov

80

primary outcome
Last imported at : April 14, 2022, 11:30 p.m.
Source : ClinicalTrials.gov

Mean duration of hospitalization.

Notes
Last imported at : July 29, 2021, noon
Source : ClinicalTrials.gov

None

Phase
Last imported at : Nov. 16, 2021, 6:30 p.m.
Source : ClinicalTrials.gov

Not reported

Arms
Last imported at : July 29, 2021, noon
Source : ClinicalTrials.gov

[{"arm_notes": "", "treatment_id": 1737, "treatment_name": "Viusid", "treatment_type": "Nutrition", "pharmacological_treatment": "Non pharmacological treatment"}, {"arm_notes": "", "treatment_id": 125, "treatment_name": "Asbrip", "treatment_type": "Vitamins and dietary supplements", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "", "treatment_id": 2188, "treatment_name": "Standard of care", "treatment_type": "Standard of care", "pharmacological_treatment": "Standard of care"}]